Application is now open for the 2025 Student Teaser Fellowship, offering a stay of at least four weeks in a European neurological host department outside your city of residence.
Join now for bonus months! Plus: October renewal discount and special benefit for associate members
October 1, 2025
Join us now and take advantage of bonus months. Active individual members enjoy October discount for renewals and associate members special a benefit!
EAN Associate Members get access to EAN Congress 2025 content for October!
September 26, 2025
Latest Posts
-
-
News in generalResearchTop Articles
New paper offers insight into patient involvement in neurological research
January 31, 2025A new paper published in Nature Reviews Neurology offers a cogent overview of patient involvement in medicine in the context of public participation in democratic processes. -
This month, the eanCampus is highlighting the topic of Sleep-wake disorders, withs several pieces of content freely accessible for non-EAN Members to enjoy,
-
EBCNews in general
Join the European Brain Council’s ‘Towards a Rare Brain Disease Ecosystem’ event in Brussels on 20 February!
January 31, 2025In the framework of Rare Disease Day, join the European Brain Council’s 'Towards a Rare Brain Disease Ecosystem' event held in Brussels on 20 February 2025! -
EAN NewsEur J Neurol
EAN and European Journal of Neurology recognise most productive reviewers of 2024
January 31, 2025The European Journal of Neurology and the European Academy of Neurology are launching a new benefit to reward our most productive reviewers from January 2024 onwards. -
EAN NewsEAN Congress newsEAN News
Tell us Your EAN Congress Story and win free congress registration!
January 30, 2025We are excited to introduce a new competition, Your EAN Congress Story, giving you the chance to win free registration for the EAN Congress 2025 in Helsinki, Finland on 21-24 June 2025! -
Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.
-
Education cornerEducation
Hold an EAN Regional Teaching Session, Day, or Course in your Country!
January 24, 2025Find out how to host EAN regional teaching events, designed to provide high-quality training to neurology residents and professionals in related specialties. -
eLearningEducation cornerEducation
Celebrate the International Day of Education with the eanCampus!
January 24, 2025We are proud to support the International Day of Education by offering a range of eanCampus content to anyone with a myEAN account! -
The next EAN Congress Masterclass in Vienna will explore the latest advancements in treatments on 28 March, on Innovative Treatments in Rare Neuroimmunological Disorders.
-
AdvocacyBrain HealthEAN NewsEur J NeurolTop Articles
EAN Roadmap paper sets path toward promoting and improving brain health
January 17, 2025A new EAN paper published in the European Journal of Neurology presents a roadmap toward reducing the burden imposed on patients, caregivers, and society by neurological diseases in Europe. -
Executive PageEAN NewsEAN Congress newsFeatured Slider
Executive Page: Submit, register, and join us for our 11th Congress in Helsinki!
January 16, 2025EAN Programme Committee Chair, Irena Rektorova, provides an extensive preview of the EAN Congress 2025, looking at programme highlights, new features, and how you can get involved! -
Welcome to the first edition of the President’s Corner, a new article series in which the EAN President, Elena Moro, answers your questions!
-
AdvocacyBrain HealthEAN NewsEAN NewsTop Articles
Lancet highlights EAN activities in call for action on brain health
January 15, 2025The Lancet Neurology highlights the urgent need to prioritise brain health in a new editorial, citing the Brain Health Mission as an example of positive initiatives aiming to promote brain health. -
EAN NewsInterviewsTop Articles
Video Interview: EMA approval of lecanemab, with Sebastiaan Engelborghs, EAN Dementia Panel Co-Chair
January 15, 2025Sebastiaan Engelborghs, Co-Chair of the EAN Scientific Panel on Dementia & Cognitive Disorders talks to EAN Communications Committee member Raphael Wurm about the recent decision by the European Medicines Agency to approve lecanemab for Alzheimer’s disease treatment.